ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 617989 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 617989; 2) Community: the network communities that were significantly associated with the response to NSC 617989; 3) Molecule: the relationships between components within communities and NSC 617989; 4) MDR: the compounds that were significantly associated with the NSC 617989.

NSC Compound Enrichment Correlation
NSC 237020 TA 1067 0.000150163566228975 0.44900748
NSC 648100 Null 0.000150163566228977 0.35087045
NSC 652809 Null 0.000150163566228977 0.35430861
NSC 724631 4,11-dihydroxy-1-[4-[[2-hydroxy-1-(hydroxymethyl)-1-methylet hyl]-mino]butyl]-1H-naphtho[2,3-f]indole-5,10-dione 0.000150163566228977 0.34017628
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.000150163566228977 0.39987673
NSC 249956 CHAPLIATRIN 0.000152553454647255 0.49581632
NSC 626879 Cyclopentanone, 2-[(dimethylamino)methyl]-5-heptylidene-, hydrochloride 0.000166573147098354 0.4780382
NSC 359463 Null 0.000174252554411806 0.50945418
NSC 663337 Null 0.000174252554411808 0.39845205
NSC 682841 Null 0.000174252554411808 0.51919053
Total:184  Current:2    [First] [Prev] [Next] [Last]